{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T13:17:01Z","timestamp":1769692621918,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002719","name":"Aligarh Muslim University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002719","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.nano.2012.07.004","type":"journal-article","created":{"date-parts":[[2012,7,31]],"date-time":"2012-07-31T11:45:26Z","timestamp":1343735126000},"page":"247-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Development, characterization and efficacy of niosomal diallyl disulfide in treatment of disseminated murine candidiasis"],"prefix":"10.1016","volume":"9","author":[{"given":"Maroof","family":"Alam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swaleha","family":"Zubair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Farazuddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ejaj","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arbab","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qamar","family":"Zia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abida","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owais","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2012.07.004_bb0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/clinids\/14.Supplement_1.S43","article-title":"Opportunistic mycoses in the immunocompromised host: experience at cancer center and review","volume":"14","author":"Anaissie","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nano.2012.07.004_bb0010","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF01962067","article-title":"The impact of changing epidemiology of fungal infections in the 1990s","volume":"11","author":"Pfaller","year":"1992","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.nano.2012.07.004_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/28.suppl_A.1","article-title":"Opportunistic and pathogenic fungi","volume":"28","author":"Richardson","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.nano.2012.07.004_bb0020","series-title":"Emerging Targets in Antibacterial and Antifungal","first-page":"249","article-title":"Invasive fungal infections: problems and challenges in developing new antifungal compound","author":"Walsh","year":"1992"},{"key":"10.1016\/j.nano.2012.07.004_bb0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0074-7696(04)42005-1","article-title":"Multidrug resistance in yeast Candida","volume":"242","author":"Prasad","year":"2005","journal-title":"Int Rev Cytol"},{"key":"10.1016\/j.nano.2012.07.004_bb0030","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1128\/AAC.39.4.906","article-title":"Detection of amphotericin B-resistant Candida isolates in a broth-based system","volume":"39","author":"Rex","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2012.07.004_bb0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1469-0691.2005.01141.x","article-title":"The need for new therapeutic agents: what is in the pipeline?","volume":"11","author":"Shah","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.nano.2012.07.004_bb0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-1605(99)00061-6","article-title":"Inhibitory effect of seven Allium plants upon three Aspergillus species","volume":"49","author":"Yin","year":"1999","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.nano.2012.07.004_bb0045","series-title":"Garlic. The science and therapeutic application of Allium sativum L. and related species","first-page":"135","article-title":"Therapeutic effects and applications of garlic and its preparations","author":"Reuter","year":"1996"},{"key":"10.1016\/j.nano.2012.07.004_bb0050","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1021\/ja01239a048","article-title":"Allicin, the antibacterial principle of Allium sativum, I: isolation, physical properties, and antibacterial action","volume":"66","author":"Cavallito","year":"1944","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.nano.2012.07.004_bb0055","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1021\/ja01222a501","article-title":"Allicin, the antibacterial principle of Allium sativum, III: its precursor and \u201cessential oil\u201d of garlic","volume":"67","author":"Cavallito","year":"1945","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.nano.2012.07.004_bb0060","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1021\/ja01239a049","article-title":"Allicin, the antibacterial principle of Allium sativum, II: determination of the chemical structure","volume":"66","author":"Cavallito","year":"1944","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.nano.2012.07.004_bb0065","series-title":"Phytomedicines of Europe: their chemistry and biological activity. ACS Symposium Series 691","first-page":"176","article-title":"Garlic: a review of its medicinal effects and indicated active compounds","author":"Lawson","year":"1998"},{"key":"10.1016\/j.nano.2012.07.004_bb0070","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/1568009033333736","article-title":"Garlic [Allium sativum]: a review of its potential use as an anti-cancer agent","volume":"3","author":"Thomson","year":"2003","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.nano.2012.07.004_bb0075","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1271\/bbb.63.588","article-title":"An organosulphur compound isolated from oil-macerated garlic extract, and its antimicrobial effect","volume":"63","author":"Yoshida","year":"1999","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.nano.2012.07.004_bb0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/(SICI)1098-1128(199601)16:1<111::AID-MED4>3.0.CO;2-5","article-title":"Therapeutic actions of garlic constituents","volume":"16","author":"Agarwal","year":"1996","journal-title":"Med Res Rev"},{"key":"10.1016\/j.nano.2012.07.004_bb0085","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1099\/0022-1317-50-7-646","article-title":"In vitro antimicrobial activity of four Diallyl sulfides occurring naturally in garlic and chinese leek oils","volume":"50","author":"Tsao","year":"2001","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.nano.2012.07.004_bb0090","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0944-7113(00)80010-0","article-title":"Allyl sulfide constituents of garlic volatile oil as antimicrobial agents","volume":"7","author":"Avato","year":"2000","journal-title":"Phytomedicine"},{"key":"10.1016\/j.nano.2012.07.004_bb0095","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1128\/aem.62.11.4238-4242.1996","article-title":"Inhibition of microbial growth by ajoene, sulfur-containing compound derived from garlic","volume":"62","author":"Naganawa","year":"1996","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.nano.2012.07.004_bb0100","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/yea.1503","article-title":"Diallyl disulfide depletes glutathione in Candida albicans: oxidative stress-mediated cell death studied by two-photon microscopy","volume":"24","author":"Lemar","year":"2007","journal-title":"Yeast"},{"key":"10.1016\/j.nano.2012.07.004_bb0105","first-page":"145","article-title":"Niosomes as carriers for ophthalmic drugs: in vitro\/in vivo evaluation","volume":"135","author":"Perini","year":"1996","journal-title":"Boll Chim Farm"},{"key":"10.1016\/j.nano.2012.07.004_bb0110","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1023\/A:1016210515134","article-title":"Distribution, metabolism and tumoricidal activity of doxorubicin administered in sorbitan monostearate (Span 60) niosomes in the mouse","volume":"12","author":"Uchegbu","year":"1995","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2012.07.004_bb0115","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.2042-7158.1988.tb05263.x","article-title":"The distribution of doxorubicin in mice following administration in niosomes","volume":"40","author":"Rogerson","year":"1988","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.nano.2012.07.004_bb0120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/10611869308996070","article-title":"Effect of macrophage activation on plasma disposition of niosomal 3H-methotrexate in sarcoma-180 bearing mice","volume":"1","author":"Chandraprakash","year":"1993","journal-title":"J Drug Target"},{"key":"10.1016\/j.nano.2012.07.004_bb0125","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1148\/radiol.2311021559","article-title":"Glucose-receptor MR imaging of tumors: study in mice with PEGylated paramagnetic niosomes","volume":"231","author":"Luciani","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.nano.2012.07.004_bb0130","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.2042-7158.1986.tb04623.x","article-title":"Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconate","volume":"38","author":"Baillie","year":"1986","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.nano.2012.07.004_bb0135","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.2042-7158.1985.tb04990.x","article-title":"The preparation and properties of niosomes non-ionic surfactant vesicles","volume":"37","author":"Baillie","year":"1985","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.nano.2012.07.004_bb0140","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1055\/s-2006-960119","article-title":"Identification and HPLC quantification of the sulpides and dialk(en)yl thiosulphinates in commercial garlic products","volume":"57","author":"Lawson","year":"1991","journal-title":"Planta Med"},{"key":"10.1016\/j.nano.2012.07.004_bb0145","first-page":"311","article-title":"In vitro release of hydrophilic and hydrophobic drugs from liposomal dispersions and gels","volume":"56","author":"Nounou","year":"2006","journal-title":"Acta Pharm"},{"key":"10.1016\/j.nano.2012.07.004_bb0150","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1046\/j.1432-1327.2000.01447.x","article-title":"Yeast vesicles as carriers for introducing macromolecules into cytoplasmic compartment of adherent cells","volume":"267","author":"Owais","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.nano.2012.07.004_bb0155","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/1061186031000119093","article-title":"Use of tuftsin bearing nystatin liposomes against an isolate of Candida albicans showing less in vivo susceptibility to amphotericin B","volume":"11","author":"Khan","year":"2003","journal-title":"J Drug Target"},{"key":"10.1016\/j.nano.2012.07.004_bb0160","series-title":"Reference method for broth dilution antifungal susceptibility testing for yeasts. Approved standard M 27-A","author":"National Committee for Clinical Laboratory Standards","year":"1995"},{"key":"10.1016\/j.nano.2012.07.004_bb0165","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.femsim.2004.03.011","article-title":"Co-administration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible Candida albicans infection in temporarily neutropenic mice","volume":"41","author":"Khan","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.nano.2012.07.004_bb0170","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/cdd.1984.1.199","article-title":"Altered tissue distribution of Amphotericin-B by liposomal encapsulation: comparison of normal mice to mice infected with Candida albicans","volume":"1","author":"Lopez-Berestein","year":"1984","journal-title":"Cancer Drug Deliv"},{"key":"10.1016\/j.nano.2012.07.004_bb0175","first-page":"351","article-title":"Liposomal Amphotericin-B in the control of experimental aspergillosis in mice: part I\u2014relative therapeutic efficacy of free and liposomal Amphotericin-B","volume":"26","author":"Ahmad","year":"1989","journal-title":"Indian J Biochem Biophys"},{"key":"10.1016\/j.nano.2012.07.004_bb0180","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/BF02570908","article-title":"Antimicrobial lipids: natural and synthetic fatty acids and monoglycerides","volume":"12","author":"Kabara","year":"1977","journal-title":"Lipids"},{"key":"10.1016\/j.nano.2012.07.004_bb0185","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1128\/AAC.45.11.3209-3212.2001","article-title":"In vitro killing of Candida albicans by fatty acids and monoglycerides","volume":"45","author":"Bergsson","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2012.07.004_bb0190","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/BF02632701","article-title":"Chromatographic analysis of sorbitan fatty acid esters","volume":"46","author":"Sahasrabudhe","year":"1969","journal-title":"J Am Oil Chem Soc"},{"key":"10.1016\/j.nano.2012.07.004_bb0195","first-page":"346","article-title":"Innate immune mechanisms for recognition and uptake of Candida species","volume":"31","author":"Netea","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.nano.2012.07.004_bb0200","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.nano.2012.07.004_bb0205","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2217\/nnm.09.60","article-title":"Efficacy of niosomal formulation of diallyl sulfide against experimental candidiasis in Swiss albino mice","volume":"4","author":"Alam","year":"2009","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.nano.2012.07.004_bb0210","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1042\/BSR20090068","article-title":"Potential use of liposomal diallyl sulfide in the treatment of experimental murine candidiasis","volume":"30","author":"Maroof","year":"2010","journal-title":"Biosci Rep"},{"key":"10.1016\/j.nano.2012.07.004_bb0215","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/MMBR.64.4.672-693.2000","article-title":"Molecular properties of bacterial multidrug transporters","volume":"64","author":"Putman","year":"2000","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.nano.2012.07.004_bb0220","first-page":"1949","article-title":"Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump","volume":"6","author":"Goren","year":"2000","journal-title":"Clin Cancer Res"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963412004054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963412004054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:08:09Z","timestamp":1761548889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963412004054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1549963412004054"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2012.07.004","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development, characterization and efficacy of niosomal diallyl disulfide in treatment of disseminated murine candidiasis","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2012.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}